Summit Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Summit Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Summit Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Summit Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $14M | 642k | 21.28 |
| 2024-12-31 | $10M | 561k | 17.85 |
| 2024-09-30 | $13M | 577k | 21.90 |
| 2024-06-30 | $2.6M | 337k | 7.80 |
| 2024-03-31 | $2.9M | 693k | 4.14 |
| 2023-12-31 | $1.8M | 704k | 2.61 |
| 2023-09-30 | $1.0M | 555k | 1.87 |
| 2023-06-30 | $1.5M | 592k | 2.51 |
| 2022-12-31 | $931k | 219k | 4.25 |
| 2022-06-30 | $0 | 209k | 0.00 |
| 2022-03-31 | $801k | 328k | 2.45 |
| 2021-06-30 | $1.8M | 218k | 8.12 |
| 2020-12-31 | $1.2M | 254k | 4.70 |
| 2020-09-30 | $723k | 210k | 3.44 |